| For: | Xu M, Ruan TT, Tang H, Fang RF, Sai WL, Xie Q, Yao DF, Yao M. Up-regulated programmed cell death protein-1/its ligand 1 expression promotes metabolic dysfunction-associated steatotic liver disease malignant progression. World J Gastrointest Oncol 2025; 17(5): 104842 [PMID: 40487954 DOI: 10.4251/wjgo.v17.i5.104842] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v17/i5/104842.htm |
| Number | Citing Articles |
| 1 |
Si-ying Wang, Dong-fang Shang, Chen-lu Zhao, Qing Zhao, Su-tong Liu, Li-hui Zhang, Wen-xia Zhao. Mitochondrial Fatty Acid Oxidation Dysregulation in Metabolic Dysfunction-Associated Steatotic Liver Disease: Mechanistic Roles and Emerging Diagnostic and Therapeutic Advances. Pharmacological Research 2026; doi: 10.1016/j.phrs.2026.109732
|
| 2 |
Yin Cai, Lu-Yin Liu, Xiao-Xiao Xia, Hao Tang, Min Xu, Wen-Li Sai, Deng-Fu Yao, Min Yao. Stemness CD24 activation promotes hepatocellular carcinoma progression <i>via</i> an immune escape mechanism. World Journal of Gastroenterology 2026; 32(3): 113187 doi: 10.3748/wjg.v32.i3.113187
|
| 3 |
Tao Ying, Liao Zhangxiu, Wei Jiankai. Association of VISTA and BTLA polymorphisms with the risk of non-HBV and non-HCV related hepatocellular carcinoma in Western Guangxi, China: a pilot case-control study. Personalized Medicine 2026; 23(5) doi: 10.1080/17410541.2026.2753779
|